Is Apyx Medical Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: APYX) stock is to Strong Buy APYX stock.
Out of 3 analysts, 3 (100%) are recommending APYX as a Strong Buy, 0 (0%) are recommending APYX as a Buy, 0 (0%) are recommending APYX as a Hold, 0 (0%) are recommending APYX as a Sell, and 0 (0%) are recommending APYX as a Strong Sell.
What is APYX's forecast return on equity (ROE) for 2023-2025?
(NASDAQ: APYX) forecast ROE is -32.19%, which is considered weak.
What is APYX's Price Target?
According to 3 Wall Street analysts that have issued a 1 year APYX price target, the average APYX price target is $7.17, with the highest APYX stock price forecast at $9.00 and the lowest APYX stock price forecast at $4.50.
On average, Wall Street analysts predict that Apyx Medical's share price could reach $7.17 by Aug 11, 2024. The average Apyx Medical stock price prediction forecasts a potential upside of 122.58% from the current APYX share price of $3.22.
What is APYX's forecast return on assets (ROA) for 2023-2025?
(NASDAQ: APYX) forecast ROA is -18.87%, which is lower than the forecast US Medical Devices industry average of 11.73%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.